highlights from a cll session: btkis, personalizing care, novel regimens, & more
Published 3 weeks ago • 55 plays • Length 3:17Download video MP4
Download video MP3
Similar videos
-
2:10
a study investigating the incidence of treatment-emergent autoimmune cytopenias in cll
-
2:08
an insight into the current understanding of risk factors for cll
-
1:06
key considerations when treating patients with cll who have pre-existing cardiovascular disease
-
2:00
associated toxicities of novel therapies for cll
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
1:16
current and future advancements in the treatment of cll
-
27:47
novel immunotherapies (car t, bispecifics, and adcs) - jeremy abramson, md
-
3:15
what is leukemia?
-
4:43
novel treatments being explored for patients with hemophilia: highlights from isth 2024
-
3:21
the cll patient journey: improving communication between physicians and patients
-
3:50
relevance of current prognostication and prediction markers for cll with new targeted therapies
-
1:56
the current landscape of all therapy research
-
1:07
primary findings from the epcore cll-1 trial of epcoritamab in cll and rt
-
0:51
long-term post hoc analysis of murano trial: host immune changes following venr treatment in cll
-
3:06
cll: the green study
-
0:49
venice ii trial: health-related qol in patients with cll treated with venetoclax
-
1:40
the clinical manifestations of cll: classical and constitutional symptoms
-
1:09
cll treatment: discussing new data from the last 3 years
-
4:20
therapy-related all: etiology, prognosis, and treatment
-
1:32
novel btki strategies in indolent b-cell malignancies: pirtobrutinib for fl and mzl
-
1:34
current research in aml